文献速递消化道出血消化内镜

急性下消化道出血出院后长期复发风险:一项大型全国性队列研究

Long-term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-06-03

该研究基于日本49家医院的CODE BLUE-J研究,回顾性分析5048例因急性下消化道出血急诊住院患者,随访期间再出血发生率为25.8%,1年和5年累积发生率分别为15.1%和25.1%,并识别出休克指数≥1、输血、院内再出血、结肠憩室出血和噻氯匹定使用等再出血危险因素。

要点

  • 急性下消化道出血出院后再出血1年累积发生率为15.1%,5年为25.1%。
  • 结肠憩室出血患者再出血风险最高(SHR 2.38),内镜止血可显著降低风险(SHR 0.83)。
  • 院外再出血患者死亡风险显著高于无院外再出血者(HR 1.42)。

核心结论

  • 大型全国性随访数据强调住院期间内镜诊断和治疗以及评估持续使用噻氯匹定的必要性,以降低院外再出血风险,并有助于识别再出血高危患者。

研究设计与样本

  • 回顾性分析日本49家医院因急性下消化道出血急诊住院的5048例患者(CODE BLUE-J研究),采用竞争风险分析(以无再出血死亡为竞争风险)分析长期再出血危险因素。

主要发现

  • 平均随访31个月期间,1304例患者(25.8%)发生再出血,1年和5年累积再出血发生率分别为15.1%和25.1%。
  • 院外再出血患者的死亡风险显著高于无院外再出血患者(风险比1.42)。
  • 多因素分析显示,休克指数≥1(SHR 1.25)、输血(SHR 1.26)、院内再出血(SHR 1.26)、结肠憩室出血(SHR 2.38)和噻氯匹定使用(SHR 1.24)与再出血风险增加显著相关。
  • 结肠憩室出血患者的多因素分析显示,输血(SHR 1.20)、院内再出血(SHR 1.30)和噻氯匹定使用(SHR 1.32)与再出血风险增加显著相关,而内镜止血(SHR 0.83)显著降低风险。

临床怎么用

  • 作者认为,住院期间应重视内镜诊断和治疗,并评估持续使用噻氯匹定的必要性,以降低院外再出血风险。
  • 作者认为,上述信息有助于识别再出血高危患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Currently, large, nationwide, long-term follow-up data on acute lower gastrointestinal bleeding (ALGIB) are scarce. We investigated long-term risks of recurrence after hospital discharge for ALGIB using a large multicenter dataset. METHODS: We retrospectively analyzed 5048 patients who were urgently hospitalized for ALGIB at 49 hospitals across Japan (CODE BLUE-J study). Risk factors for the long-term recurrence of ALGIB were analyzed by using competing risk analysis, treating death without rebleeding as a competing risk. RESULTS: Rebleeding occurred in 1304 patients (25.8%) during a mean follow-up period of 31 months. The cumulative incidences of rebleeding at 1 and 5 years were 15.1% and 25.1%, respectively. The mortality risk was significantly higher in patients with out-of-hospital rebleeding episodes than in those without (hazard ratio, 1.42). Of the 30 factors, multivariate analysis showed that shock index ≥1 (subdistribution hazard ratio [SHR], 1.25), blood transfusion (SHR, 1.26), in-hospital rebleeding (SHR, 1.26), colonic diverticular bleeding (SHR, 2.38), and thienopyridine use (SHR, 1.24) were significantly associated with increased rebleeding risk. Multivariate analysis of colonic diverticular bleeding patients showed that blood transfusion (SHR, 1.20), in-hospital rebleeding (SHR, 1.30), and thienopyridine use (SHR, 1.32) were significantly associated with increased rebleeding risk, whereas endoscopic hemostasis (SHR, 0.83) significantly decreased the risk. CONCLUSIONS: These large, nationwide follow-up data highlighted the importance of endoscopic diagnosis and treatment during hospitalization and the assessment of the need for ongoing thienopyridine use to reduce the risk of out-of-hospital rebleeding. This information also aids in the identification of patients at high risk of rebleeding.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sato Y, Aoki T, Sadashima E, et al. Long-term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study. Clin Gastroenterol Hepatol. 2023. PMID: 37276989. doi:10.1016/j.cgh.2023.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。